Blog

Follow us for the latest trends, insights and
innovations in the pharmaceutical industry.
Blog banner about payment terms for pharmaceutical intermediates, risk balance between buyer and supplier, T/T, L/C, D/P, D/A comparison and 7 common buyer mistakes

Payment Terms for Intermediates: 7 Buyer Mistakes to Avoid

This guide compares T/T, L/C, D/P and D/A for pharmaceutical intermediate purchases, with worked costs on a $60,000 order and the seven mistakes buyers make.
Read More →
Blog cover about impurity fate mapping for pharmaceutical intermediates, purge assessment and COA limitations, ICH M7 Option 4 pharmaceutical quality analysis graphic, professional dark‑blue‑grey tech background

Impurity Fate Mapping: 5 Documents Buyers Should Request

An impurity absent from a Certificate of Analysis is not necessarily absent from the process — it may simply have been purged downstream. This guide ...
Read More →
Dual Sourcing for API Intermediates buyer qualification checklist, pharmaceutical supply chain risk management for generic drug manufacturers

Dual Sourcing for API Intermediates: A Buyer’s Qualification Checklist

This checklist shows buyers how to qualify a second supplier in six steps — documentation, batch consistency, quality agreements, and activation triggers included.
Read More →
Comparison cover for custom synthesis and catalog pharmaceutical intermediates buyer decision‑making framework

Custom Synthesis vs Catalog Intermediates: A Buyer’s Decision Framework

This article presents a buyer's decision framework built on six factors: specification match, lead time predictability, total cost of ownership, batch-to-batch consistency, documentation depth, and ...
Read More →
Scroll to Top

Contact us to Get the Best Product Solution